Nicoya Lifesciences is launching FastHDX, a hydrogen-deuterium exchange mass spectrometry platform to measure protein ...
A proteomics data pipeline transforms raw mass spectrometry spectra into biologically interpretable protein-level ...
Explore how proteomics enables personalized medicine by improving patient stratification, treatment response, and diagnostics ...
Neurodegenerative disorders such as Alzheimer's disease (AD) are typically diagnosed after irreversible pathology has developed. Aging, the strongest risk factor, drives molecular changes that ...
Researchers from the MPI of Biochemistry and the Technical University of Munich have discovered new diagnostic markers for multiple sclerosis (MS), a disease that affects 3 million people worldwide.
Neurodegenerative disorders such as Alzheimer's disease (AD) are typically diagnosed after irreversible pathology has developed. Aging, the strongest risk factor, drives molecular changes that ...
New advisors bring decades of industry drug discovery leadership and foundational scientific expertise across Proxima's ...
Nicoya Lifesciences, Inc., a leading provider of advanced biophysical characterization tools for biologics discovery and development, today announced the launch of FastHDX, a new hydrogen-deuterium ...
Rising Pharmaceutical R&D Spending, Expanding Clinical Diagnostics Demand, and Rapid Advancement in Mass Spectrometry and Multi-Omics Technologies Accelerate Global Proteomics Market Growth.Austin, ...
Forget “ eye of newt and toe of frog/wool of bat and tongue of dog.” People in the 16th century were more akin to DIY ...
Gene therapy that can cross the blood–brain barrier represents a non-invasive way to map gene expression in the brains of ...
From analytical control through downstream processes to manufacturing, BsAbs present challenges in protein expression, purity, and stability.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results